Author: Erin Kutz

  • For A123, Government Funding Brings Both Job Creation and Innovation, CEO Says

    A123Systems logo (updated version)
    Erin Kutz wrote:

    A123Systems president and CEO David Vieau says some investors have questioned whether the company’s aggressive pursuit of federal funding for lithium-ion battery production is a sign that the company doesn’t have a sustainble business without government support.

    But for A123 (NASDAQ: AONE), “it really is about jobs,” Vieu said yesterday at a fireside chat-style discussion at the IdeaStream Symposium, put on by MIT’s Deshpande Center for Technological Innovation. “We do feel a sense of social responsibility to create jobs to the extent that we can do it and give our shareholders a good return.”

    A123, whose nanoscale electrode technology comes out of MIT, was initially funded in 2001 with a $100,000 grant from the U.S. Department of Energy, but grew over the last decade to pull off a $380 million IPO in September 2009.

    A123’s first product, a battery for handheld electric tools, was used by Black & Decker, but the company has since evolved to focus on batteries for electric vehicles. It put its first production facilities in Asia because the region possesses all the materials, equipment, manufacturing, and development knowledge surrounding lithium-ion battery production, says Vieau. “If we had been able to do it in the US from the beginning, we would have,” he says.

    Last year, A123 won a $249 million grant as part of the DOE’s push for electric vehicles, and used the funding to begin construction on its first U.S. manufacturing facility in Livonia, MI. The federal backing is enabling A123 to maximize the value of its technology for shareholders, Vieau says. The company will outfit electric cars from automakers such as Chrysler, Navistar, and Fisker Automotive with batteries produced at the Michigan plant.

    At its first Livonia site A123 has worked on “duplicating the Korean factory as exactly as we possibly can” in order to get its products out most efficiently, Vieau says. But with future Michigan factory installations, the company hopes to innovate in its manufacturing facilities to become more efficient and survive without government backing.

    Though state and federal funding, including $100 million in tax breaks, were what convinced A123 to put its first U.S. manufacturing plants in Michigan, it’s also realized other benefits from working on the ground alongside the auto industry.

    “It’s been much much better than I ever expected in terms of the innovation ability,” Vieau says. For one, automotive engineers have a keen ability to adhere to a tight production schedule—a feat those in the IT world, which Vieau comes from, have a harder time matching, he says.

    UNDERWRITERS AND PARTNERS



























  • Nokia Acquires Metacarta, Massachusetts Taps EnerNOC and FloDesign, MedVentive Gets Backing from Clarian Health, & More Boston-Area Deals News

    Erin Kutz wrote:

    After a slower flow of high-tech transactions last week, dealmaking was back with a bang this week. Companies in industries from energy to e-commerce to life sciences scored early venture rounds, partnership deals, and state contracts.

    —Gemvara, an e-commerce site for jewelry customizations, announced it raised $5.2 million in Series B money, bringing the Lexington, MA-based company’s total financing to $11 million since its founding. Return investors Highland Capital Partners and Canaan Partners led the round, which comes as the company searches for a new CEO.

    FloDesign Wind Turbine, of Wilbraham, MA, will get $3 million from the Massachusetts Clean Energy Center, as it plans to expand with a new headquarters and product development center in Waltham, MA, which should add about 150 jobs in the state over three years. FloDesign, which is developing wind turbines with jet engine-like technology, will keep its Wilbraham location as an aerodynamics research center.

    —MedVentive, a Waltham-based electronic medical data software firm, revealed the investors behind its $10 million Series C round. Boston’s HLM Venture Partners and Excel Venture Management led the financing, which included Long River Ventures, as well as new investors Core Capital Partners and Clarian Health Ventures, the venture arm of one of MedVentive’s big customers. Clarian Quality Partners, the physician network of the Indianapolis-based healthcare provider, uses MedVentive’s technology to analyze the quality of doctor care.

    —Cambridge, MA-based Metacarta, a maker of software for searching digital text on places, names, and addresses, was acquired by Finland’s mobile hardware giant Nokia. Financial terms weren’t disclosed. Nokia plans to use Metacarta’s technology for in-location local searches and other services, according to a statement.

    Newton, MA’s MedMinder Systems, a company that makes Internet-connected pillboxes for tracking patients’ prescription adherence, raised $1.3 million from 11 individual investors. MedMinder is part of a crop of Boston-area companies using IT to get patients to take their meds, including Cambridge-based Vitality, a maker of smart pillcaps.

    —The state of Massachusetts was active in this week’s deals list. It announced it had awarded a contract to Boston-based EnerNOC (NASDAQ: ENOC) as part of a $10 million project to target energy inefficiencies in state facilities. The program will …Next Page »










  • $7M Goes to Searchandise

    Erin Kutz wrote:

    Searchandise Commerce, a Beverly, MA-based company that provides an online media network for manufacturers and retail partners, has landed $7 million in Series 2 financing, led by Seattle’s Madrona Venture Group, the company announced today. Existing Searchandise investors Cloquet Capital Partners, DFJ Gotham Partners, Draper Associates, Inflection Point Ventures, Milestone Venture Partners, and Wheatley Partners also participated in the funding round, which will go to expanding Searchandise’s sales, marketing, and operations teams. Wade wrote about the company in 2008 after it landed $7.5 million and changed its name from Guidester.

    UNDERWRITERS AND PARTNERS



























  • MicroCHIPS, Nimbit, and Xcellerex Hire New CEOs

    Erin Kutz wrote:

    There’s the old saying that things happen in threes. That’s true this week in Boston, where three tech companies have announced new CEOs. Two of the moves came in the life science sector, at MicroCHIPS and Xcellerex, and the third involved online music marketing site Nimbit. Read below for the details on each company’s new chief executive hire.

    —Bedford, MA-based MicroCHIPS, a maker of wireless medical implants with chemical sensors or drug reservoirs, announced its appointment of Ajit Gill as president and CEO. Gill comes from Auspex Pharmaceuticals, and previously led Nektar Therapeutics, a biotech startup he helped take public. MicroCHIPS pulled in a $16.5 million Series C round in January and is slated to take its technology from development to clinical testing later this year. Gill replaces the company’s founder and CEO John Santini, Jr., who will continue to consult for MicroCHIPS and has become CEO of On Demand Therapeutics, a joint venture between MicroCHIPS and InterWest Partners that is working on novel technology for the delivery of drugs to the eye.

    Nimbit, an online portal for directly connecting musicians, managers, and music labels to fans, announced it hired board member Bob Cramer as chief executive officer. Cramer, who has held management positions in a range of online and software companies and will continue to serve as chairman of Nimbit, joins the Framingham, MA-based company’s co-founders Phil Antoniades and Patrick Faucher, who will move from CEO to chief technology officer. Nimbit packages marketing, sales, and distribution for musicians, through offerings such as e-mail and social media outreach, merchandise and ticket sales, and fan and marketing analytics.

    Xcellerex, a Marlborough, MA-based company developing methods for manufacturing biomolecules more efficiently, announced that Thermo Fisher Scientific veteran Guy Broadbent has been appointed as president, CEO, and a member of the board of directors. He succeeds Joseph Zakrzewski, who will remain chairman of the company’s board of directors. The hiring of Broadbent, who ran Thermo Fisher’s laboratory products division and worked as a senior vice president of corporate development, comes as Xcellerex moves into the next phase of commercializing its technology, the company says.

    UNDERWRITERS AND PARTNERS



























  • Massachusetts Venture Funding Slimmed Down to $194 Million in March, But Healthcare Investing Swelled

    Erin Kutz wrote:

    It’s no question that March was a disorderly month. Here in New England, 70-degree days were quickly followed by record flooding for the region. The NCAA tournament saw major upsets in nearly every round (only for Duke to win the championship in the end.) Oh, and a little something called healthcare reform was signed into law, after a year of raucous town hall meetings, bitter debate, and talk of baby killers and death panels.

    The venture investing patterns in the Bay State last month followed much the same rocky, incongruent path marked by highs and lows. Some sectors rose to heightened levels of dominance, while some disappeared from the startup-investing scheme completely. It all amounted to $194.5 million raised across 17 deals, a slight drop from the month before, when Bay State startups wrapped up $203 million in 26 equity deals. The funding totals made March a pretty average month since we started tracking monthly venture investing in June, thanks to data provided by our New York-based partner CB Insights, a private company intelligence platform. (Five months had higher venture investing totals, and four months fell behind March in dollars raised).

    The New England region wasn’t in the only place to experience slowed venture investing last month; Seattle-area deal making fell to $21.3 million across a mere three deals, down from $53.5 million in 10 deals in February. It is worth noting that the 17 transactions in Massachusetts in March tied for the lowest number of deals since we started tracking these numbers. But the fact that March’s 17 deals amounted to about $50 million more than the $145 million raised across 17 deals last June shows that the size of individual transactions might be growing.

    If there’s something to brag about from last month, it’s the life sciences sector. Healthcare funding soared to $144.2 million, which represents nearly 75 percent of the venture dollars raised in March. The number of healthcare deals for February and March was even at nine, but the March totals dwarfed the February tally of $89.9 million. All told, healthcare companies

    MarchVentureTotals

    took up the five highest deal slots in March, and the sector pulled in roughly $120 million more than the runnerup category, Internet.

    The biggest transaction was the $35.4 million that went to TransMedics, an Andover, MA-based developer of systems for transporting organs for transplant. Foundation Capital, Kleiner Perkins Caufield & Byers, and Flagship Ventures participated in the round, which included about $9 million of convertible debt.

    Gene therapy developer Genetix Pharmaceuticals was right at its heels with the second biggest deal: $35 million in Series B money. The Cambridge-based company attracted new investors Third Rock Ventures and Genzyme Ventures for the round.

    As previously mentioned, Internet came in second as a sector, with $24.2 million across five deals in March. This might …Next Page »

    UNDERWRITERS AND PARTNERS



























  • Tap ‘n Tap Raises $2.25M Series A

    Erin Kutz wrote:

    Tap ‘n Tap, a Cambridge, MA-based company designing software platforms for touch-screen Internet devices, has completed a $2.25 million Series A funding round, led by New Atlantic Ventures, says company president Javier Segovia. The company reported $1.6 million of the cash in a regulatory filing on Friday, but Segovia says the company has raised a total of $2.25 million, from both New Atlantic and angel investors. We wrote about Tap ‘n Tap last month when the company crossed our under-the-radar funding list with a $500,000 equity deal in February, which contributed to the round.







  • BlueShift Sells IP to Brooks

    Erin Kutz wrote:

    Andover, MA-based BlueShift Technologies, a maker of systems for semiconductor equipment manufacturing, has sold its intellectual property to Chelmsford, MA-headquartered Brooks Automation (NASDAQ: BRKS), Dow Jones VentureWire reported today. The move comes after BlueShift was unable to land another round of venture funding, VentureWire reported. BlueShift backers include Atlas Venture, North Bridge Venture Partners, and Intel Capital, according to the company’s website.

    UNDERWRITERS AND PARTNERS



























  • Demandware Bumps Series D to $22M

    Erin Kutz wrote:

    Demandware, a Woburn, MA-based provider of hosted e-commerce storefronts, has upped its Series D round of financing to $22 million, an amended SEC filing reveals. We wrote about the first $15 million the company pulled in for the round last April, from North Bridge Venture Partners and General Catalyst Partners. The amended filing lists North Bridge’s Michael Skok, General Catalyst’s Larry Bohn, and Sears veteran Paul Miller as Demandware directors.










  • MA Hires EnerNOC to Find Energy Savings

    Erin Kutz wrote:

    The state of Massachusetts has contracted with Boston-based EnerNOC (NASDAQ: ENOC) to employ its energy-tracking software systems to monitor 17 million square feet of state-owned facilities, using federal stimulus dollars set aside for energy investments, Governor Deval Patrick’s office announced today. The state has put $10 million toward what it calls the Enterprise Energy Management System project, which would use EnerNOC’s technology in its initial three-year phase to track real-time energy usage and target inefficiencies in 470 state buildings. The project is expected to add about 46 jobs in the state starting next month, and could save more than $10 million annually in energy costs once a planned second phase of the project is complete, the governor’s office said.

    UNDERWRITERS AND PARTNERS



























  • MedMinder Grabs $1.3M

    Erin Kutz wrote:

    MedMinder Systems, a Newton, MA-maker of “smart” pillboxes that track patients’ prescription adherence, has raised $1.265 million in equity-based funding, according a filing with the SEC. The filing notes that the round came from 11 investors, which CEO Eran Shavelsky says include entrepreneurs as well as faculty from MIT who also helped the company raise about $500,000 two years ago. Last month Ryan tracked companies such as MedMinder that are using wireless and Internet technologies to remind patients to take their meds and enhance communication on the subject with care providers.

    UNDERWRITERS AND PARTNERS



























  • Selecta Scores $15M, Fate Expands into Canada, Xconomy Launches Health IT Channel, & More Boston-Area Life Sciences News

    Erin Kutz wrote:

    With the world aflutter over Apple’s iPad release, it seemed this week was all about IT, making it a lighter life sciences news week for us. The two spaces don’t have to be mutually exclusive, though; a fact we showcased with the launch of our new Health IT channel.

    —Ryan introduced Xconomy’s Health IT channel, a new section of the website dedicated to the increasing flow of news on how the healthcare industry is using technology to better manage patient care. The channel includes a feature entirely new to our site: App Watch, which aims to keep readers up-to-date on health-oriented mobile and Web products, which do everything from helping you buy healthier groceries and tracking your workouts, to taking your vital signs and transmitting the data to healthcare providers.

    Selecta Biosciences, a Watertown, MA-based vaccine developer, raised $15 million in Series C money, to put towards development of nanoparticles, which are key components of what it hopes will be a new generation of more effective vaccines. New investor OrbiMed Advisors led the funding, which included a slew of existing backers, and adds to the $15 million the company raised in February 2009.

    —Cambridge, MA-based Dyax (NASDAQ: DYAX) added another $8 million to its stock offering when underwriter Jefferies & Company exercised its over-allotment option to purchase an additional 2.55 million shares of common stock at $3.25 per share. The company sold 17 million shares at $3.25 apiece in March, but the underwriter deal, which closed on Monday, bumped up the total net proceeds from the offering to $59.6 million.

    —Speaking of Health IT, I caught up with Vitality, a Cambridge startup that’s making Internet-connected pill caps that remind people to take their meds on time. The company, whose technology also aims to target the psychological reason behind why people skip out on their prescriptions, is rolling out a pilot program with pharmacy benefit manager Express Scripts later this month. Pharma companies lose major revenue streams when patients take pills less often than they’re prescribed, a problem Vitality CEO David Rose hopes will push the drugmakers to employ his system.

    —San Diego-based Fate Therapeutics, a stem cell technology developer that also sponsors research labs in Boston and Seattle, announced it will acquire Ottawa, Canada-based Verio Therapeutics, which has drug candidates that could be useful in regenerating damaged pancreatic and heart cells. Fate, which seeks to use stem cell science to create drugs that enable the body’s cells to repair and regenerate tissue, didn’t disclose financial details of the deal.

    UNDERWRITERS AND PARTNERS



























  • FloDesign Gets $3M, Plans to Expand

    Erin Kutz wrote:

    Wilbraham, MA’s FloDesign Wind Turbine will get $3 million in funding from the Massachusetts Clean Energy Center, as it plans to expand its operation in the state with the addition of a new corporate headquarters and product development center in Waltham, the state announced today. FloDesign, which is developing wind turbines with technology reminiscent of jet engines, will keep its Wilbraham location as an aerodynamics research center. The new funding will come in the form of a $600,000 convertible grant that could give the Clean Energy Center an equity stake in the company, $1.7 million from the center’s Renewable Energy Trust, and a $700,000 five-year forgivable loan, which requires FloDesign to add 150 jobs in the state over three years and maintain them for another two years. Wade caught up with FloDesign’s new CEO in January, days after the company announced it had raised $35 million in Series B funding.

    UNDERWRITERS AND PARTNERS



























  • RunMyErrand Is Now TaskRabbit

    Erin Kutz wrote:

    RunMyErrand, a Boston-based Internet startup that helps users outsource errands and odd jobs, has changed its name to TaskRabbit to reflect the wide spectrum of tasks the site is used for, the company announced today. The website is also unleashing new features, such as the ability to put tasks out for bid by multiple “runners” (the people who do the tasks), and the ability to pay for services as you go instead of purchasing credits before posting tasks, which it previously required members to do. TaskRabbit has backing from Baseline Ventures and Maples Investments, both in California.










  • ThredUP Site Aims to Tie Together Loose Strings of Children’s Used Clothing Market

    thredUP
    Erin Kutz wrote:

    Cambridge, MA-based thredUP’s mission is simple: to be “the place where America’s busiest families exchange clothing for kids,” says co-founder and CEO James Reinhart.

    The idea came to him in November 2008, when he was staring at a closet full of clothes that he no longer wanted to wear, he says. Last October, the company launched an e-commerce site for peer-to-peer exchanges of men’s and women’s shirts, but it has quickly evolved to focus on more miniature clothing consumers.

    ThredUP seeks to get apparel that kids have outgrown in the hands of others it would fit. The average U.S. family spends about $1,000 a year outfitting their rapidly growing tots, says Reinhart. “Our goal is to supplement that experience to save parents money,” he says.

    Setting up an exchange on thredUP is designed to take about 10 minutes from start to finish. Users can browse boxes containing 10 to 18 children’s clothing items, based on factors such as gender, size, season, or clothing items. Once a user selects a box they’d like, the thredUP site automatically sends the box’s creator an e-mail instructing them to ship it.

    Once a user has picked a box, it’s expected they’ll put together a box themselves; a process the site walks them through. They select the child’s age, gender, and size from dropdown menus. Next they choose exactly how many of each clothing item they’re packing, and further qualify that by selecting the season of the clothing, at least three brands the box includes, the most prominent colors in the collection, and any additional descriptions.

    The site even automatically generates a shipping label for the exchange, which users can print out on their home computer, and stick on free postal boxes.ThredUP helps users order the postal boxes, and schedules the time when the clothes can be picked up right from their home.

    “The whole thing has been designed for super ease of use,” says Reinhart, who’s expecting his first child this summer. “We think so many websites don’t button it up the full way.”

    At this point users can build kids’ boxes on the site, but the exchanges won’t go live until early next week. The kids’ site has accrued more than 1,000 users in the two weeks it’s been up, Reinhart says.

    Shoppers pay $13 to send and receive one box, which mainly goes to shipping costs of the exchange. ThredUP makes …Next Page »







  • Gemvara Grabs $5.2M

    Erin Kutz wrote:

    Lexington, MA-based Gemvara, an online jewelry customization marketplace, has raised $5.2 million in Series B funding, led by returning investors Highland Capital Partners and Canaan Partners, the company announced today. Gemvara, which changed its name from Paragon Lake in February when it revamped its jewelry store-focused business as a direct-to-consumer website, will use the new funding for marketing and improving customer experience. CEO Deborah Besemer stepped down last month, leaving founder Matt Lauzon in charge as the company looks for an executive with more e-commerce experience. The Series B financing brings Gemvara’s total funding pot to $11 million.










  • SS&C Prices IPO, Amag Gets $60M from Takeda, Selecta Nabs $15M, & More Boston-Area Deals News

    Erin Kutz wrote:

    Looks like the recent Boston sunshine helped plump up deal flow for the region’s software, Internet, and life sciences companies.

    —Financial services software company SS&C Technologies Holdings, of Windsor, CT, set its IPO price at $15 a share, for a total of 10.725 million new shares. The price was at the high end of SS&C’s earlier proposed range. The initial public offering was worth nearly $161 million and put SS&C stock trading on the NASDAQ under the ticker symbol SSNC.

    Hangout Industries, a software platform provider for social games targeted toward teens, raised $2 million from existing investors, including Highland Capital Partners and Polaris Venture Partners. The Boston-based company’s CEO told Mass High Tech that another $3 million could be on the way, bringing Hangout’s funding total to $15 million.

    —Lexington, MA-based Amag Pharmaceuticals (NASDAQ: AMAG) grabbed $60 million in upfront cash from a deal that gives Japan-based Takeda Pharmaceutical exclusive license rights to all therapeutic uses of ferumoxytol, Amag’s treatment for iron deficiency anemia, in Europe, former Soviet states, Asia Pacific countries (excluding China, Japan, and Taiwan), Canada, and Turkey.

    —Cambridge, MA-based Cequent Pharmaceuticals and Bothell, WA’s MDRNA (NASDAQ: MRNA) announced they would merge in a $46 million, all-stock deal. The merger, expected to close in July, will …Next Page »










  • $12M Series D for Brightcove

    Erin Kutz wrote:

    Brightcove, the Cambridge, MA-based online video hosting company, has pulled in a $12 million Series D funding round, led by Accel Partners and General Catalyst Partners, the company confirmed in its corporate blog today. Existing Brightcove investors, including AOL, Hearst, AllianceBernstein, Maverick Capital, and Brookside Capital, participated in the financing round, which will go toward new product rollouts, expansion in Asia and Europe, research and development, and possible mergers and acquisitions. Last week Wade wrote about the company’s plans to expand its offerings to non-Flash devices such as the iPhone and iPad.










  • Vitality’s Internet-Connected GlowCap Targets Behavior Change to Remind You to Stay on Meds

    Vitality GlowCaps
    Erin Kutz wrote:

    Some people feel guilty when evading their doctor’s recommendations; others need a logical reason to follow an instruction. Cambridge, MA-based Vitality tries to factor in these differences in motivations and psychological makeup to spur patients toward a common goal: to make sure they take their medications as prescribed.

    On its most basic level, Vitality’s GlowCap system functions to remind users of when they’re forgetting their prescriptions. It involves an Internet-connected pill cap that also sends signals to a device that resembles a nightlight. When a deadline is missed, the system will blink and sound an alarm, which gets louder as time goes by. If the medication is still not taken, GlowCaps generate an automated phone call to the user to remind them to take a pill and ask them why they’ve forgotten it so far.

    “We have a device that notices right in the moment that someone is making a decision and intervenes right away,” says founder and CEO David Rose, who previously founded and ran Ambient Devices, a Cambridge-based company that pioneered the use of household devices like clocks to convey information to people, on everything from the stock market to the weather.

    The answers culled in these phone calls, in addition to initial interview questions with the user, help the Vitality system create a profile and determine the forces that motivate them, such as authority, social support, or rewards. Rose says there are many reasons beyond forgetfulness that users skip meds, such as concerns of cost, side effects, or lack of education on the effects of their disease. The GlowCaps system aims to both prevent those factors from becoming hindrances, and implement services that encourage users to take their drugs in the future, based on their individual psychological profiles.

    For example, if the co-pay costs of a prescription cause a patient to skip meds, the system could help implement financial incentives for users who take their prescription when they’re supposed to. For patients motivated by authority figures, the system can help coordinate regular reports with their doctors, documenting their prescription adherence. GlowCaps helps coordinate refills with a patient’s pharmacy, too.

    It also offers the capability to e-mail your adherence rate to a selected friend or family member, if you’re someone who is spurred by social support. Many patients taking medications to treat diseases that don’t cause immediate discomfort, such as high blood pressure, osteoporosis, or high cholesterol, are more inclined to skip pills. Vitality can target this user with regular, interactive, educational e-mails on the long-term effects of their disease.

    “Just like an exquisite friend or boyfriend, we try to make a system that learns to adapt over time with what happens to work for you,” Rose says.

    Wade wrote about the Vitality when the company’s Ethernet-connected device hit Amazon.com in August, selling for $99 each directly consumers, skewed toward baby boomers who need a way to keep their aging parents on track with taking medication. But Rose has since evolved his business to market and test-drive the product alongside bigger organizations. And Vitality has a new version of the GlowCap device, which uses a cellular network to connect to the Internet, and will be used in future distribution programs.

    Later this month the company will …Next Page »

    UNDERWRITERS AND PARTNERS



























  • Another $8M for Dyax in Stock Deal

    Erin Kutz wrote:

    Dyax (NASDAQ: DYAX), a Cambridge, MA-based developer of a drug for an inflammatory disease, has raised $59.6 million in a stock deal. Last month the company raised $51.8 million through the sale of 17 million shares at $3.25 per share, and raised an additional $8 million when underwriter Jefferies & Company exercised its over-allotment option to purchase an additional 2.55 million shares of common stock at $3.25 per share, in a sale that closed today. The funding from the stock offering will go to Dyax’s Kalbitor (ecallantide), a drug for treating acute attacks of an inflammatory disease called hereditary angioedema.

    UNDERWRITERS AND PARTNERS



























  • CareFusion Gets Medegen for $225M

    Erin Kutz wrote:

    CareFusion (NYSE: CFN), a San Diego-based medical device company, announced today that it will acquire Medegen, a maker of disposable systems for delivering medication intravenously, for $225 million in cash. The acquisition of Ontario, CA-based Medegen will be the first for CareFusion, which became a publicly traded company in September 2009 after spinning off from Cardinal Health. CareFusion said Medegen’s systems, which help reduce blood infections associated with intravenous systems, will be a strategic fit with its portfolio of infusion products.

    UNDERWRITERS AND PARTNERS